ESOP15 May 2026, 05:51 pm
Gland Pharma Grants 690,019 Stock Options Under ESOP 2025
AI Summary
Gland Pharma Ltd has granted 690,019 employee stock options to 124 employees under its ESOP 2025 scheme. The grant was approved by the ESOP Compensation Committee on May 15, 2026, and adheres to SEBI regulations. 455,413 options are priced at ₹934.15 each (50% of the closing price on May 15, 2026), and 234,606 options are priced at ₹1 each. The options will vest in three tranches: 34% on May 15, 2027, 33% on May 15, 2028, and 33% on May 15, 2029, and can be exercised within two years of vesting.
Key Highlights
- Gland Pharma grants 690,019 stock options to 124 employees under ESOP 2025.
- 455,413 options are priced at ₹934.15, and 234,606 options at ₹1.
- Vesting schedule: 34% in 2027, 33% in 2028, and 33% in 2029.
- Options can be exercised within two years from the vesting date.
- The grant complies with SEBI (Share Based Employee Benefits) Regulations, 2021.
Price Impact
More from GLAND